Product Information
CLONAZEPAM 1 MG DIS TABLET is a generic product labeled by Par Health USA, LLC, priced at $0.5546 per EA under NDC 49884030902. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 3, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Par Health USA, LLCNDC
49884030902
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077171FDA Approved
8/3/2005
TE Code
AB
On Market Since
8/5/2005
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 1 MG DIS TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 23.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5546 per EA |
|---|---|
| All-time high | $0.9293 (Nov 16, 2016) |
| All-time low | $0.4241 (Mar 22, 2023) |
| 52-week high | $0.5921 |
| 52-week low | $0.4879 |
| Median price | $0.7530 |
| Average price | $0.7245 |
| Largest weekly change | +48.7% (Jun 19, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 1 MG DIS TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG DIS TABLET, manufactured by Par Health USA, LLC, is $0.5546 per EA (NDC 49884030902), effective Aug 19, 2026.
How has the price of CLONAZEPAM 1 MG DIS TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 1 MG DIS TABLET has declined 23.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG DIS TABLET?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 1 MG DIS TABLET has ranged from a low of $0.4241 (Mar 22, 2023) to a high of $0.9293 (Nov 16, 2016), with a median of $0.7530 per EA.
Are there cheaper alternatives to CLONAZEPAM 1 MG DIS TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLONAZEPAM 1 MG TABLET, is $0.0245 per EA — about 96% below CLONAZEPAM 1 MG DIS TABLET.
Who manufactures CLONAZEPAM 1 MG DIS TABLET?
CLONAZEPAM 1 MG DIS TABLET (NDC 49884030902) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.